- Home
- KURA vs SENEB Comparison
KURA vs SENEB Comparison
Compare KURA & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | SENEB |
|---|---|---|
| Founded | 2014 | 1949 |
| Country | United States | United States |
| Employees | N/A | 6895 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 765.8M | 880.5M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | SENEB |
|---|---|---|
| Price | $8.91 | $135.00 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.56 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 181.0 |
| Earning Date | 05-12-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | ★ N/A | $12.93 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $90.19 |
| 52 Week High | $12.49 | $164.98 |
Technical Indicators
Market Signals| Indicator | KURA | SENEB |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 52.32 |
| Support Level | $8.09 | $108.68 |
| Resistance Level | $10.34 | $164.98 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | -0.06 | -1.84 |
| Stochastic Oscillator | 26.25 | 10.59 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.